
Sign up to save your podcasts
Or


Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval.
By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?
Guest:
Peter Aldhous, science reporter at Buzzfeed News
Host
Lizzie O’Leary
Hosted on Acast. See acast.com/privacy for more information.
By Slate Podcasts4.4
231231 ratings
Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval.
By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?
Guest:
Peter Aldhous, science reporter at Buzzfeed News
Host
Lizzie O’Leary
Hosted on Acast. See acast.com/privacy for more information.

9,221 Listeners

1,067 Listeners

8,494 Listeners

4,045 Listeners

7,859 Listeners

10,712 Listeners

1,378 Listeners

3,538 Listeners

1,026 Listeners

2,843 Listeners

1,000 Listeners

1,030 Listeners

500 Listeners

5,626 Listeners

1,874 Listeners

53 Listeners

2,071 Listeners

23,879 Listeners

10,235 Listeners

7,227 Listeners

2,401 Listeners

1,283 Listeners

5,455 Listeners

1,195 Listeners

447 Listeners

5,527 Listeners

16,022 Listeners

60 Listeners

48 Listeners

98 Listeners

7 Listeners

131 Listeners

0 Listeners